Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.74 - $12.87 $225,274 - $1.67 Million
129,468 Added 821.03%
145,237 $315,000
Q3 2022

Nov 14, 2022

SELL
$7.21 - $14.88 $4,686 - $9,672
-650 Reduced 3.96%
15,769 $189,000
Q2 2022

Aug 15, 2022

BUY
$5.97 - $9.97 $54,882 - $91,654
9,193 Added 127.22%
16,419 $137,000
Q1 2021

May 12, 2021

BUY
$8.63 - $10.94 $62,360 - $79,052
7,226 New
7,226 $66,000

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $81.7M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.